Human Relaxin-2 – Cardiovascular & Connective Tissue Research

Human Relaxin-2 is a naturally occurring peptide hormone belonging to the insulin/IGF/relaxin family. It is primarily produced during pregnancy and plays a role in cardiovascular adaptation, connective tissue remodeling, and regulation of reproductive physiology. In research contexts, Relaxin-2 has been studied for its potential effects on vasodilation, fibrosis reduction, and tissue repair.

Each vial contains 10mg of high-purity Human Relaxin-2, designed for advanced laboratory applications.

Research Potential

Human Relaxin-2 has been investigated for:

• Vasodilation and cardiovascular regulation
• Anti-fibrotic mechanisms
• Wound healing and tissue regeneration
• Reproductive system physiology
• Organ protection models

Scientific Background

Relaxin-2 binds to the RXFP1 receptor, activating pathways that enhance nitric oxide production and reduce collagen deposition. In experimental models, this activity has shown promise for cardiovascular health, fibrosis prevention, and enhanced tissue elasticity.

Its unique profile makes it a valuable research candidate for both acute and chronic conditions involving tissue stiffness or vascular resistance.

Chemical Profile

Type: Recombinant human peptide hormone
Form: Lyophilized powder
Purity: ≥98% (HPLC)
Molecular Formula: C_256H_404N_72O_76S_10
Appearance: White to off-white powder

Produced under strict quality controls for in vitro laboratory research only.

Storage & Handling

Store lyophilized product at −20°C. After reconstitution, refrigerate at 2–8°C and use within the recommended stability window. Avoid repeated freeze–thaw cycles.

For Research Use Only

This product is intended for in vitro laboratory research only and is not for human or veterinary use.

• Relaxin – Wikipedia
• Peptide Hormone – Wikipedia
• Fibrosis – Wikipedia